Cita APA

Liu, N., Feng, J., Lu, X., Yao, Z., Liu, Q., Lv, Y., . . . Zhou, Y. (2019). Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways. Mediators Inflamm.

Citación estilo Chicago

Liu, Ning, Jiao Feng, Xiya Lu, Zhilu Yao, Qing Liu, Yang Lv, Yuru Han, Jingfan Deng, y Yingqun Zhou. "Isorhamnetin Inhibits Liver Fibrosis By Reducing Autophagy and Inhibiting Extracellular Matrix Formation Via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways." Mediators Inflamm 2019.

Cita MLA

Liu, Ning, et al. "Isorhamnetin Inhibits Liver Fibrosis By Reducing Autophagy and Inhibiting Extracellular Matrix Formation Via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways." Mediators Inflamm 2019.